Inside information completion of the public issuance of the second tranche of 2026 corporate bonds in the PRC
Filed with HKEX · Stock code 3320 · · 2 pages · English
Summary by 6ix AI
China Resources Pharmaceutical Group Ltd. has completed the public issuance of the second tranche of its corporate bonds in the PRC. The proceeds will be used for various production expenditures, including debt repayment and project development. Shareholders and potential investors are advised to exercise caution when dealing in the company's securities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
China Resources Pharmaceutical Group Ltd. on 6ix
Earlier from China Resources Pharmaceutical
- Inside information potential issuance of shares by CR pharmaceutical commercial
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Interim Report 2026
- Dividend currency election form for the interim dividend for the six months ended 30 June 2026
- AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry
Later from China Resources Pharmaceutical
- Inside information completion of the issue of the third tranche of the medium term notes 2026 in the prc
- Announcement unaudited financial results of tasly pharmaceutical for the nine months ended 30 September 2026
- Announcement unaudited financial results of dong-e-e-jiao for the nine months ended 30 September 2026
- Announcement unaudited financial results of cr jiangzhong for the nine months ended 30 September 2026
- Announcement unaudited financial results of kpc for the nine months ended 30 September 2026
Follow China Resources Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Pharmaceutical